Robot-assisted retroperitoneal lymph node dissection feasible for metastatic testicular cancer
A robotic-assisted retroperitoneal lymph node dissection (RARLND) is technically feasible and recommended in highly selected patients with low volume metastatic testicular cancer, suggests a study. In addition, RARLND has comparable complications and early oncologic safety to open surgery.